In the wake of nCino's successful debut, GoHealth's public offering proved to be a more peaceful affair, at least when comparing the two companies' initial trading days.
GoHealth above the expected IPO range, selling more shares than initially expected in the process. Selling 43.5 million shares for $ 21 each - $ 1 per share more than its previous $ 18 to $ 20 range high and four million more shares than its 39.5 million target - the insurance technology company has put over $ 900 million a week into its balance sheet.
The debut is a victory for Chicago's industry and tech scenes. GoHealth was worth just under $ 6.7 billion at its IPO price, not counting the shares that could be sold to its subscribers, which would have increased its valuation.
Despite its better-than-expected price, however, GoHealth stocks declined in afternoon trading, slipping to $ 19.00 per share, down 9.5% at the time of writing. The drop is at odds with recent nCino debuts, Lemonade and others, who saw their shares immediately gain value after they went public.
The GoHealth CEO, however, stressed his company's long-term vision in an interview with ProWellTech. Speaking to Clint Jones during GoHealth's first trading day, the executive told ProWellTech that his company's offer had been over-subscribed and had achieved the goal of accumulating long-term investors during the IPO process. .
The company plans to hire with its new funds, including another 1,000 authorized insurance agents, said the CEO.
Asked if the company plans to acquire smaller companies with its IPO funds, Jones told ProWellTech that it could be "opportunistic" regarding purchasing technology platforms or smaller teams with a particular talent. For the many start-ups competing in other parts of the insurance market world - ProWellTech has largely covered the space, including a series of rounds of financing for insurtech startups - a newly wealthy public company could provide an interesting opportunity to Exit.
The company's strong IPO price, if somewhat slowed down by trading on the first day, is akin to a washout for associated and smaller companies that watch its public offering with interest; how GoHealth's progress in the future could help set the tone for selecting insurtech startup ratings.
For today, however, we still have another unicorn that offers all the technology. GoHealth's path to the public market has not been as simple as some, but it has come the same.
